Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
List view / Grid view
News
Pill for breast cancer diagnosis may outperform mammograms
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
FDA grants orphan drug designation to elamipretide for LHON
The FDA granted Orphan Drug Designation to elamipretide, for the treatment of Leber's hereditary optic neuropathy...
3-D printing is transforming care for congenital heart disease
3-D printing is an emerging technology that is impacting the way cardiologists treat patients with congenital heart disease...
Cancer drug helps treat tuberculosis by restoring leaky blood vessels
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
Calcium-based MRI sensor enables more sensitive brain imaging
System detects direct signals of neural activity; could reveal patterns underlying behaviour...
Denosumab reduces glucocorticoid-induced bone loss
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients...
MS drug could reduce painful side effects of common cancer treatment
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib...
Experimental arthritis drug prevents stem cell transplant complication
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants...
Researchers 3-D print electronics and cells directly on skin
Groundbreaking technology could help soldiers on the battlefield and people with skin disorders...
Porton Pharma Solutions and Codexis launch global partnership
Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business...
Thermo Fisher Scientific announces first-ever cloud-based application for connectivity to electronic pipettes
Life science researchers working across many applications can now benefit from the first-ever web-based pipetting application, developed to enable seamless connectivity with electronic pipettes for optimised performance and safe, efficient and rapid sharing of protocols...
Thermo Fisher Scientific announces its first Cloud-Enabled Biological Safety Cabinet
The Thermo Scientific HeraSafe 2030i BSC is designed to optimise contamination control and accelerate productivity across challenging cell culture applications...
New breakthrough cell culture management technology designed for optimal sample protection
The Thermo Scientific Cell Locker system segregates cells for safe simultaneous growth in a single incubator...
